Carcinoid crisis
Vasoactive surge · Metabolic
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
A surge of vasoactive substances from a carcinoid tumour causes flushing, bronchospasm and unstable blood pressure, often triggered by procedures. Octreotide is the treatment.
Assessment
Investigations
- Recognise the trigger/history
- Monitoring
- Bloods
Management
- Octreotide to control the crisis
- Supportive haemodynamic care
- Avoid catecholamines where possible
- Treat bronchospasm
- Specialist involvement
Drugs & doses
Octreotide
Disposition
HDU/ICU; specialist.
Octreotide, not adrenaline, is the key treatment for carcinoid crisis hypotension.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.